We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00003176
Recruitment Status : Unknown
Verified January 2007 by National Cancer Institute (NCI).
Recruitment status was:  Active, not recruiting
First Posted : April 7, 2004
Last Update Posted : December 16, 2008
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)